EBV: Clinical Trials

3 trials for EBV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow EBV: new trials by email Literature Review of EBV trials Research Report on EBV

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults
EBV gp350-Ferritin Vaccine - EBV, Epstein-Barr Virus Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)832022-03-292026-08-13
Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)
CTL for CMV seropositive donors, CTL for CMV naïve donors - EBV, CMV
Phase 1CompletedCatherine Bollard272014-02-012025-07-03
Cytotoxic T Cells to Prevent Virus Infections
Cytotoxic T lymphocytes (CTLs). - CMV, EBV
Phase 1CompletedChildren's National Research Institute102013-09-012020-07-14

Narrower conditions

Adenoviridae Infections (2)  ·  Epstein-Barr Virus Infections (1)  ·  Infectious Mononucleosis (1)

Broader conditions

DNA Virus Infections (3)  ·  Infections (3)  ·  Virus Diseases (3)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukocyte Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Tumor Virus Infections (1)

Sponsors

Catherine Bollard (1)  ·  Children's National Research Institute (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (3)

Top investigators

Catherine Bollard, MD (1)  ·  Catherine M Bollard, M.D (1)  ·  Jessica R Durkee-Shock, M.D. (1)

Results publications

PMID 31219185, PMID 42311676